Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Talking therapy shows promise for MG patients with depression in tiny pilot study

NCT ID NCT07649187

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether having a tendency toward depression affects how well people with thymoma-associated myasthenia gravis (MG) respond to psychological counseling. Nineteen adults who had surgery for thymoma and MG received eight sessions of counseling based on Gestalt therapy and Somatic Experiencing. Researchers measured changes in daily functioning, quality of life, and well-being before and after the sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psychological counseling (Gestalt therapy and Somatic Experiencing)
What this could lead to
If successful, this could point toward personalized counseling approaches for myasthenia gravis patients with depressive symptoms.
What could go wrong
This is a very small pilot study with only 19 participants and no control group, so results may not apply to everyone. The intervention is behavioral, not a drug, so effects are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

19 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. A confirmed diagnosis of MG associated with thymoma and prior completion of surgical treatment 2. Age ≥ 20 years 3. Ability to communicate clearly and provide reliable responses 4. Absence of cognitive impairment or severe psychiatric illness that could interfere with participation 5. Willingness to participate in the study with provision of written informed consent Exclusion Criteria: 1. The absence of a confirmed diagnosis of myasthenia gravis 2. Failure to confirm thymoma on postoperative pathological examination 3. Inability to communicate adequately in Mandarin, Taiwanese, English, or written form 4. The presence of conditions that could compromise verbal communication or regular participation in counseling sessions, such as significant traumatic brain injury, severe psychiatric disorders, or cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activities of daily living are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Depression depressive disorder myasthenia gravis Psychological Well-Being thymoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shin Kong Wu Ho-Su Memorial Hospital

    Taipei, Taipei, 111045, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.